Page 825 - ACCCN's Critical Care Nursing
P. 825

802  I N D E X

         haemolysis elevated liver enzymes and low   incidence of  309          HPS see hepatopulmonary syndrome
                platelets (HELLP) syndrome  716,   indications for  309–311     HRCNZ see Health Research Council of New
                718t, 720b                    lifestyle issues  319                    Zealand
         haemorrhage                          nursing management postoperatively     HREC see human research ethics committees
           antepartum see antepartum haemorrhage   311–317                      HRS see hepatorenal syndrome
           intracerebral see intracerebral hemorrhage  acute rejection  313, 313t, 318t  HSV see herpes simplex virus
           obstetric see obstetric haemorrhage  acute renal failure  315, 318t  Hudson face mask  383
           post heart transplantation  315, 318t  allograft dysfunction and failure  315–317,   human research ethics committees (HREC)
           postpartum see postpartum               318t                                91–93
           subarachnoid  463–464, 464t          cardiac tamponade  315, 318t    humidification  389
         haemorrhagic stroke  463               denervation  317, 318t            absolute  389
         haemostasis system, pregnancy physiology   haemorrhage  315, 318t        heated  389
                adaptation of  714, 714t        hyperacute rejection  313         heat-moisture exchanger  389
         haemostatic capability impairment      immunosuppression therapy  313–314,   relative  389
                contributors  299–300              314t                         Hunt-Hess scale  464t
         haemothorax  636                       infection  314–315, 318t        hybrid  786
         HAI see hospital-acquired infection    left ventricular dysfunction  316–317, 318t  hydrocephalus  448
         Hancock II porcine aortic valve  295f  rhythm strip  312f              hygiene
         hand hygiene  120, 120b                right ventricular dysfunction  316, 318t  basic personal  106–107
         handheld technologies  48–49         outcomes from  309                  hand  120, 120b
         Hawthorne effect  42                 surgery forms  311                  oral  109–110
         HCM see hypertrophic cardiomyopathy    heterotopic  311, 312f            personal see personal hygiene
         HCO 3  see bicarbonate                 orthotopic  311, 312f           hyperacute rejection, of heart
             –
         HE see hepatic encephalopathy       HeartMate®USA  310f                       transplantation  313
         head of bed elevation, invasive mechanical   heat exhaustion  786      hypercapnoeic respiratory failure  353–354
                ventilation and  402         heat illness  615                  hyperglycaemia, critical illness and see diabetes
         Health Act 1956  80                 heat stroke  786                   hyperglycaemic hyperosmolar non-ketotic state
         Health and Disability Ethics Committees  91–92  heated humidity (HH)  389     (HHNS)  526, 786
         Health Research Council of New Zealand   heat-moisture exchanger (HME)  122, 389, 786  treatment of  528t
                (HRCNZ)  82, 91–92           HELLP see haemolysis elevated liver enzymes   hyperkalaemia, burns and  648
           Operational Standard for Ethics         and low platelets syndrome   hypertension
                Committee  82                heparin  114, 786                    intracranial  448–449, 449f–450f
         healthcare associated infections  121–122, 122b  citrate compared to, research vignettes  502b  see also intracranial hypertension
         health-related quality of life (HRQOL)  57–59  for CRRT  496, 496t       post cardiac surgery  296
           depression and  63                 reversal  300                       post heart transplantation  319
           measurement of  59–60, 59t        hepatic encephalopathy (HE)  518, 786  in pregnancy see preeclampsia
         heart disease see coronary heart disease  hepatic failure, fulminant  786  hypertensive emergencies  242–243
         heart failure  227–241              hepatobiliary changes, pregnancy and  714  hyperthermia  453, 615
           causes of  228                    hepatopulmonary syndrome (HPS)  519  hypertrophic cardiomyopathy (HCM)  241–242
           chronic see chronic heart failure  hepatorenal syndrome (HRS)  518, 786  hyperventilation, for intracranial hypertension
           congestive, NIV for  390–391      herpes simplex virus (HSV)  465–466       management  452
           left ventricular  230, 230t       heterotopic heart transplantation  311, 312f  hypocalcaemia  569
           NYHA functional classification of  231, 233t  heterotropic  786      hypocaloric intake  510
           pathology of  228                 HFNC see high-flow nasal cannulae  hypotension
           pathophysiology of  229f          HFOV see high frequency oscillatory ventilation  post cardiac surgery  296–297
           prevalence of  227–228            HFPSF see heart failure with preserved systolic   sepsis-induced  788
           responses to  228–230                   function                     hypothalamic-pituitary-adrenal (HPA) axis  786
             Frank-Starling curve  228–229, 229f  HH see heated humidity        hypothalamus  423–424, 786
             neurohormonal  228, 230         HHNS see hyperglycaemic hyperosmolar non-  hypothermia  614–615, 628
             RAAS  228–229                         ketotic state                  accidental, research vignette  650b–651b
             sympathetic nervous system  228, 229f  HHS see Department of Health and Human   burns and  648
           right ventricular  230–231, 230t        Services                       physiological effects of  614t
           signs and symptoms of  228        high frequency oscillatory ventilation   after SCA  671, 671b, 673b–674b
         heart failure with preserved systolic function   (HFOV)  401           hypoventilation  381–382
                (HFPSF)  236f                 in children  694                  hypovolaemia  542
         heart rate                          high-degree atrioventricular block  261, 261f  hypovolaemic shock  542–545
           calculation of, on ECG  195       high-flow nasal cannulae (HFNC)  382  blood product adverse reactions  546t
           pregnancy and  712                hindbrain  421t–422t                 clinical manifestations of  542–543
           regulation of, autonomic nervous system   histamine-2-receptor antagonists (H 2 RAs)  516  collaborative management of  544–545
                control and  188–189         HME see heat-moisture exchanger      fluid resuscitation in  543
         heart sounds, auscultation of  191–192, 191t  home-based care  71–72     independent practice in  543–544
           first  191                        homunculus  423, 424f                massive blood transfusion and
           second  191                       hormonal and neural regulation in renal   indicators for  544f
           late diastolic  191                     system  482–483                 physiological derangements of  543f
           murmurs  191–192, 192t             acid-base regulation  483, 483f     nursing practice in  543–545
           pericardial rub  191               ADH  482                            platelet administration guidelines  545t
           stethoscope placement for  191t    ANP  483                            preload management of  544–545
           ventricular gallop  191            electrolyte balance  483            red blood cell administration guidelines
         heart transplantation  308–319       endocrine organ role  483                545t
           complications from, long-term      RAAS  482–483, 482f                 signs and symptoms of  543t
             cardiac allograft vasculopathy  317–318  SNS  482                  hypoxaemia  333–334, 334f
             hypertension  319               Hospital Anxiety and Depression Scale   oxygen optimisation compensatory
             malignancy  318                       (HADS)  61                          mechanisms  334
             renal dysfunction  318–319      hospital-acquired infection (HAI)  121–122  refractory  401–402
           costs associated with  311        hospital-acquired pneumonia  358–359  ECMO  401–402
           history of  308–309               HPA see hypothalamic-pituitary-adrenal axis  HFOV  401
   820   821   822   823   824   825   826   827   828   829   830